Vaccination to prevent shingles also reduces the risk of developing dementia in later life, according to a research paper published recently in Nature. This conclusion is based on the analysis of ...

A shingles shot may do more than prevent rash — it could help shield the aging brain from dementia, according to a landmark study using real-world data from the UK. Study: A natural experiment ...

A vaccine to fight dementia? It turns out there may already be one–shots that prevent painful shingles and also appear to protect aging brains.A new study found shingles vaccination cut older ...

The duration of mild shingles cases can vary from person to person. The rash and other symptoms of shingles typically last 2 to 4 weeks. However, milder cases may clear up sooner than more severe ...

We will report on the new companies as they hang new shingles. Watch on Deadline Get our Breaking News Alerts and Keep your inbox happy. Signup for Breaking News Alerts & Newsletters ...

It also involves painful blisters, but it strikes during adulthood. We’re talking about shingles. And unlike chickenpox, the timeline for recovering from shingles can span weeks, months ...

We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn and work.

Two words come to mind for Elizabeth Banks after her showdown with shingles: "Not fun." The "Hunger Games" and "Pitch Perfect" actress and director actually missed work for the first time in her ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for ...

LONDON, March 25 (Reuters) - GSK (GSK.L), opens new tab said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its best-selling shingles ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. Rise and shine, everyone, another busy day is on the way.